PLAY PODCASTS
Robinhood Joins S&P; Oracle Upgrades; Summit Therapeutics Plunges

Robinhood Joins S&P; Oracle Upgrades; Summit Therapeutics Plunges

Stock Movers

September 8, 20254m 22s

Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

On this episode of Stock Movers:
- Robinhood (HOOD) is gaining this morning after S&P Dow Jones Indices said it would be added to the S&P 500 Index. Applovin (APP) is higher this morning as well as it will be added. The stocks will be replacing MarketAxess Holdings, Caesars Entertainment and Enphase Energy; the changes are effective prior to the open of trading on Monday, Sept. 22. Bloomberg Intelligence analyst Neil Sipes says “Robinhood’s addition to the S&P 500 will expand its shareholder base, underscoring its profit progress toward incumbent brokers.”
- Echostar (SATS) shares are rising on news SpaceX agreed to acquire wireless spectrum from EchoStar for about $17 billion in cash and stock. SpaceX is buying EchoStar’s AWS-4 and H-block spectrum licenses and will pay as much as $8.5 billion in cash and up to $8.5 billion in SpaceX stock. The acquisition would allow SpaceX to offer its own direct-to-device offerings more independently, and is expected to resolve inquiries from the US Federal Communications Commission.
- Summit Therapeutics (SMMT) is plunging after the drug developer gave longer-term follow-up data from a global trial of its investigative lung cancer therapy, ivonescimab, that disappointed Wall Street.
- Oracle (ORCL) is higher after its price target was raised at JPMorgan, Morgan Stanley, and Barclays.

See omnystudio.com/listener for privacy information.